2,297
Views
27
CrossRef citations to date
0
Altmetric
Commentary

The resurgence of mumps and pertussis

&
Pages 955-959 | Received 08 Oct 2015, Accepted 22 Oct 2015, Published online: 10 Mar 2016

References

  • Rubin S, Plotkin S. Mumps Vaccine, In: Plotkin S, Orenstein W, Offit PA, eds. Vaccines. Philadelphia: Saunders, 2013:419-46
  • Edwards KM, Decker MD. Pertussis Vaccine, In: Plotkin S, Orenstein W, Offit PA, eds. Vaccines. Philadelphia: Saunders, 2013:447-92
  • Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill 2013; 18: pii:20587; PMID:24084340; http://dx.doi.org/10.2807/1560-7917.ES2013.18.38.20587
  • Braeye T, Linina I, De RR, Hutse V, Wauters M, Cox P, Mak R. Mumps increase in Flanders, Belgium, 2012–2013: results from temporary mandatory notification and a cohort study among university students. Vaccine 2014; 32:4393-8; PMID:24973734; http://dx.doi.org/10.1016/j.vaccine.2014.06.069
  • Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol 2012; 20:211-3; PMID:22494804; http://dx.doi.org/10.1016/j.tim.2012.03.003
  • Gabutti G, Azzari C, Bonanni P, Prato R, Tozzi A E, Zanetti A, Zuccotti G. Pertussis: Current perspectives on epidemiology and prevention. Hum Vaccin Immunother 2015; 11(1):108-17; PMID:25483523; http://dx.doi.org/10.4161/hv.34364
  • Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G. Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum Vaccin Immunother 2015; 11:1413-7; PMID:25874726; http://dx.doi.org/10.1080/21645515.2015.1021522
  • Burgmeijer R, Hoppenbrouwers K, Hahné S. Bof (parotitis epidemica), In: Burgmeijer R, Hoppenbrouwers K, Van Gompel F, eds. Handboek Vaccinaties. Assen: Van Gorcum 2013:3-12
  • Mahieu L, De SK, Van den Branden D, Boeckx H, Mahieu H, Wojciechowski M. Epidemiology of pertussis in children of Flanders Belgium: can healthcare professionals be involved in the infection? Acta Clin Belg 2014; 69: 104-10; PMID:24724749; http://dx.doi.org/10.1179/0001551214Z.00000000032
  • Pierard D. Bordetella Pertussis. Report national reference centre 2013; 2014, 1-8.
  • Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, Miller E, Chen RT. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 1998; 351:356-61; PMID:9652634; http://dx.doi.org/10.1016/S0140-6736(97)04334-1
  • Burgmeijer R, Hoppenbrouwers K. Kinkhoest (pertussis), In: Burgmeijer R, Hoppenbrouwers K, Van Gompel F, eds. Handboek vaccinaties. Assen: Van Gorcum 2013: 246-68
  • Laenen J, Roelants M, Devlieger R, Vandermeulen C. Influenza and pertussis vaccination coverage in pregnant women. Vaccine 2015; 33:2125-31; PMID:25796339; http://dx.doi.org/10.1016/j.vaccine.2015.03.020
  • Mooi FR, Van Der Maas NA, de Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect 2014; 142:685-94; PMID:23406868; http://dx.doi.org/10.1017/S0950268813000071
  • Rubin SA, Link MA, Sauder CJ, Zhang C, Ngo L, Rima BK, Duprex WP. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol 2012; 86:615-20; PMID:22072778; http://dx.doi.org/10.1128/JVI.06125-11
  • Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis 2008; 198:508-15; PMID:18558869; http://dx.doi.org/10.1086/590115
  • Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 2014; 5:e01074; PMID:24757216; http://dx.doi.org/10.1128/mBio.01074-14
  • Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 2012; 19:1703-4; PMID:22914363; http://dx.doi.org/10.1128/CVI.00367-12
  • Fine PEM, Mulholland K. Community Immunity, In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Philadelphia: Saunders, 2013: Chapter 71
  • Braeckman T, Lernout T, Top G, Paeps A, Roelants M, Hoppenbrouwers K, Van DP, Theeten H. Assessing vaccination coverage in infants, survey studies versus the Flemish immunisation register: achieving the best of both worlds. Vaccine 2014; 32:345-9; PMID:24269616; http://dx.doi.org/10.1016/j.vaccine.2013.11.041
  • Weinberg GA, Szilagyi PG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis 2010; 201:1607-10; http://dx.doi.org/10.1086/652404
  • Rubin SA, Vandermeulen C. Mumps virus, In: Samal S, ed. The biology of Paramyxoviruses. Caister Academic Press, 2011:5-36
  • Jokinen S, Osterlund P, Julkunen I, Davidkin I. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis 2007; 196:861-7; PMID:17703416; http://dx.doi.org/10.1086/521029
  • Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine 2004; 22:2713-6; PMID:15246601; http://dx.doi.org/10.1016/j.vaccine.2004.02.001
  • Vandermeulen C, Clement F, Roelants M, Van DP, Hoppenbrouwers K, Leroux-Roels G. Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination. J Infect Dis 2009; 199:1457-60; http://dx.doi.org/10.1086/598482
  • Vandermeulen C, Verhoye L, Vaidya S, Clement F, Brown KE, Hoppenbrouwers K, Leroux-Roels G. Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice. Immunology 2010; 131:33-9; PMID:20586811
  • Edwards KM, Berbers GA. Immune responses to pertussis vaccines and disease. J Infect Dis 2014; 209 Suppl 1:S10-S15; http://dx.doi.org/10.1093/infdis/jit560
  • WHO SAGE pertussis working group. Background paper, In: SAGE, ed. 2014
  • Cassone A, Ausiello CM, Urbani F, Lande R, Giuliano M, La SA, Piscitelli A, Salmaso S. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Arch Pediatr Adolesc Med 1997; 151:283-9; PMID:9080938; http://dx.doi.org/10.1001/archpedi.1997.02170400069013
  • Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013; 9:e1003264; PMID:23592988; http://dx.doi.org/10.1371/journal.ppat.1003264
  • Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.org/10.1128/CVI.00131-10
  • Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis 2013; 56:1458-65; PMID:23386629; http://dx.doi.org/10.1093/cid/cit048
  • Ogbuanu IU, Kutty PK, Hudson JM, Blog D, Abedi GR, Goodell S, Lawler J, McLean HQ, Pollock L, Rausch-Phung E, et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics 2012; 130:e1567-74; PMID:23129075; http://dx.doi.org/10.1542/peds.2012-0177
  • Zepp F, Heininger U, Mertsola J, Bernatowska E, Guiso N, Roord J, Tozzi AE, Van Damme P. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11:557-70; PMID:21600850; http://dx.doi.org/10.1016/S1473-3099(11)70007-X